Prelude Therapeutics (PRLD.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

Prelude Therapeutics Reports Third Quarter Earnings, Highlights Oncology Pipeline Progress

04:42

Nov12

Prelude Therapeutics released FY2025 Q3 earnings on November 12 During-Market EST, actual revenue USD 6.5 M (forecast USD 0), actual EPS USD -0.259 (forecast USD -0.3666)

21:00

Prelude Therapeutics released FY2025 9 Months earnings on November 12 During-Market (EST), actual revenue USD 6.5 M, actual EPS USD -1.0923

21:00

Nov5

Prelude Therapeutics to Release FY2025 Q3 Earnings on November 12 During-Market EST, Forecast EPS USD -0.3666

00:09

Oct29

Prelude Therapeutics to Report Q3 2025 Earnings

08:56

Aug15

Prelude Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.8332

03:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 6.5 M, Net Income -19.73 M, EPS -0.259

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -31.23 M, EPS -0.4109

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -32.09 M, EPS -0.4222

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change